You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Herpes virus

Showing 1 - 25 of 7,789
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Frequency of Symptomatic Herpes Virus I and II in HIV Infected

Recruiting
  • HIV Disease
  • +2 more
  • Blood draw
  • Los Angeles, California
    Global Research Institute
Apr 9, 2023

Herpes Virus Infections in Kidney Transplant Patients

Recruiting
  • Kidney Transplant; Complications
  • +2 more
    • Aarhus, Denmark
    • +4 more
    Jan 30, 2023

    Virus, HSV-1, Herpes Simplex 1 Trial in Pocatello, Saint George (Purell Hand Sanitizer, Medical Grade Mineral Oil)

    Recruiting
    • Virus
    • +3 more
    • Purell Hand Sanitizer
    • Medical Grade Mineral Oil
    • Pocatello, Idaho
    • +2 more
    Nov 13, 2023

    Herpesviruses Reactivation In Hiv-Infected Women Initiating ART

    Completed
    • Herpes Virus-Related Illnesses
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Oct 20, 2022

      Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

      Completed
      • Neonatal Herpes Simplex Infection
      • +7 more
        • Copenhagen, Denmark
        • +1 more
        Dec 25, 2022

        HSV Trial (Pritelivir)

        Available
        • HSV
        • (no location specified)
        Apr 25, 2023

        Neonatal Herpes Simplex Infection Trial in Birmingham (Valacyclovir)

        Recruiting
        • Neonatal Herpes Simplex Infection
        • Birmingham, Alabama
          University of Alabama - Children's of Alabama
        Sep 12, 2022

        NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

        Suspended
        • HSV-2 Infection
        • Herpes Simplex Virus Infection
        • Diagnostic Test: NOWDx HSV-2 Test
        • Tempe, Arizona
        • +2 more
        Sep 29, 2022

        Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia Trial (Acyclovir)

        Not yet recruiting
        • Pneumonia, Viral
        • +4 more
        • (no location specified)
        Nov 16, 2023

        Chronic Fatigue Syndrome Trial in Stanford (valganciclovir)

        Completed
        • Chronic Fatigue Syndrome
        • Stanford, California
          Stanford University Medical Center
        May 23, 2022

        Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

        Recruiting
        • Sarcoma
        • +9 more
        • Recombinant oncolytic herpes simplex virus type 1 (R130)
        • Linyi, Shandong, China
          Linyi Central Hospital
        Jul 25, 2023

        Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

        Recruiting
        • Sarcoma
        • +8 more
        • Recombinant oncolytic herpes simplex virus type 1 (R130)
        • Shanghai, Jiangsu, China
          Xuzhou Second People's Hospital
        May 8, 2023

        Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?

        Recruiting
        • Cervical Cancer
        • +2 more
        • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
        • Shanghai, Shanghai, China
          Shanghai Tenth People's Hospital
        Mar 31, 2023

        Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))

        Recruiting
        • Osteosarcoma
        • +3 more
        • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
        • Xi'an, Shaanxi, China
          Xi'an Honghui Hospital
        May 8, 2023

        Herpes Labialis Trial in Germany (drug, behavioral, procedure)

        Active, not recruiting
        • Herpes Labialis
        • HDIT101 (blinded therapy)
        • +5 more
        • Berlin, Germany
        • +4 more
        Jan 26, 2023

        Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus

        Recruiting
        • Ovarian Cancer
        • +2 more
        • Recombinant oncolytic herpes simplex virus type 1 (R130)
        • Shanghai, Shanghai, China
          Shanghai Tenth People's Hospital
        Mar 26, 2023

        Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus

        Recruiting
        • Head and Neck Cancer
        • +6 more
        • Recombinant oncolytic herpes simplex virus type 1 (R130)
        • Shanghai, China
          Eye & ENT Hospital of Fudan University
        Apr 13, 2023

        Herpes Simplex-virus Type 1 (HSV-1) Reactivation

        Recruiting
        • Tracheobronchitis
        • Herpes Simplex Infection
        • Patients with herpes-simplex infection requiring bronchoscopy
        • Münster, Germany
          University Hospital Münster
        Apr 11, 2022

        Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

        Recruiting
        • Lung Cancer
        • +11 more
        • Recombinant oncolytic herpes simplex virus type 1 (R130)
        • Anqing, Anhui, China
          The PLA Navy Anqing Hospital
        May 23, 2023

        Intravenous Acyclovir in Oncologic Paediatric Patients

        Active, not recruiting
        • Herpesviridae Infections
        • +4 more
        • Pharmacokinetic analysis
        • Trieste, TS, Italy
          IRCCS Burlo Garofolo, Bone Marrow Transplant Unit, Institute for
        Jan 19, 2022

        Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)

        Not yet recruiting
        • Genital Herpes Simplex Type 2
        • BNT163
        • Placebo
        • (no location specified)
        Jun 21, 2022

        Herpes Simplex Oral Trial in Murray (EDTA, Abreva)

        Enrolling by invitation
        • Herpes Simplex Oral
        • Murray, Utah
          University of Utah MidValley Dermatology
        Jan 25, 2022

        Melanoma Trial in Beijing (OH2 injection, HX008 injection)

        Recruiting
        • Melanoma
        • OH2 injection
        • HX008 injection
        • Beijing, Beijing, China
          Peking University Cancer Hospital
        Jan 28, 2023

        Herpes Simplex Virus Keratitis Trial in New York (oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily, oral acyclovir 400 mg

        Withdrawn
        • Herpes Simplex Virus Keratitis
        • oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily
        • oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops
        • New York, New York
          New York University School of Medicine
        Dec 29, 2021

        Recurrent Genital Herpes Trial (UB-621)

        Not yet recruiting
        • Recurrent Genital Herpes
        • UB-621
        • (no location specified)
        May 16, 2022